Neogenomics (NEO) Return on Capital Employed (2011 - 2026)
Neogenomics (NEO) posted Return on Capital Employed of 8.38% for Q1 2026, up 7.52% quarter-over-quarter from 9.06% in Q4 2025, and down 171.0% year-on-year from 11.8% in Q1 2025.
Neogenomics (NEO) Return on Capital Employed (2011 - 2026) Analysis & Trends
Neogenomics (NEO) has reported Return on Capital Employed for 16 consecutive years, with 8.38% the latest figure, recorded in Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 8.38%, down 171.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 8.38% (down 171.0% YoY), and the FY2025 annual result was 8.21%, down 143.0% from the prior year.
- Return on Capital Employed was 8.38% for Q1 2026 at Neogenomics, up from 9.06% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 6.52% in Q1 2024 and troughed at 10.23% in Q3 2022.
- Average Return on Capital Employed over 5 years is 8.14%, with a median of 8.23% recorded in 2025.
- Year-over-year, Return on Capital Employed tumbled 830 bps in 2022 and jumped 298 bps in 2023.
- Over 5 years, Return on Capital Employed stood at 9.51% in 2022, then advanced by 28 bps to 6.8% in 2023, then declined by 1 bps to 6.88% in 2024, then sank by 32 bps to 9.06% in 2025, then rose by 8 bps to 8.38% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 8.38% in Q1 2026, 9.06% in Q4 2025, and 9.4% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 4.82% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 8.12% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 6.26% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 67.98% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -3.63% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 14.57% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 10.24% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 16.90% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 45.73% |
| 10 | Neogenomics | 1.93 Bn | 1.79 Bn | 80.86 Mn | -8.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.38% |
| Dec 31, 2025 | -9.06% |
| Sep 30, 2025 | -9.40% |
| Jun 30, 2025 | -8.23% |
| Mar 31, 2025 | -6.67% |
| Dec 31, 2024 | -6.88% |
| Sep 30, 2024 | -6.86% |
| Jun 30, 2024 | -7.05% |
| Mar 31, 2024 | -6.52% |
| Dec 31, 2023 | -6.80% |
| Sep 30, 2023 | -7.25% |
| Jun 30, 2023 | -8.14% |
| Mar 31, 2023 | -8.59% |
| Dec 31, 2022 | -9.51% |
| Sep 30, 2022 | -10.23% |
| Jun 30, 2022 | -10.01% |
| Mar 31, 2022 | -8.81% |
| Dec 31, 2021 | -6.59% |
| Sep 30, 2021 | -3.96% |
| Jun 30, 2021 | -1.71% |